Ishita Drugs and Industries Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 43.31 million compared to INR 38.3 million a year ago. Revenue was INR 43.43 million compared to INR 38.4 million a year ago. Net income was INR 1.55 million compared to INR 1.37 million a year ago. Basic earnings per share from continuing operations was INR 0.52 compared to INR 0.46 a year ago. Diluted earnings per share from continuing operations was INR 0.52 compared to INR 0.46 a year ago.
For the nine months, sales was INR 101.17 million compared to INR 99.3 million a year ago. Revenue was INR 102.17 million compared to INR 99.81 million a year ago. Net income was INR 4.3 million compared to INR 3.79 million a year ago. Basic earnings per share from continuing operations was INR 1.44 compared to INR 1.27 a year ago. Diluted earnings per share from continuing operations was INR 1.44 compared to INR 1.27 a year ago.